Natera, Inc. (NTRA) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 1293 transactions totaling $376.5M, demonstrating a bearish sentiment with -$353.4M in net insider flow. The most recent transaction on Feb 3, 2026 involved a sale of 1,334 shares valued at $307.8K.
No significant insider buying has been recorded for NTRA in the recent period.
No significant insider selling has been recorded for NTRA in the recent period.
Based on recent SEC filings, insider sentiment for NTRA is bearish with an Insider Alignment Score of 3/100 and a net flow of -$353.4M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Natera, Inc. (NTRA) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading NTRA stock, having executed 1293 transactions in the past 90 days. The most active insider is Steven Leonard Chapman (Executive), who has made 282 transactions totaling $145.4M.
Get notified when executives and directors at NTRA file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 3, 2026 | Rabinowitz Daniel | SEC. AND CHIEF LEGAL OFFICER | Sale | 1,334 | $230.77 | $307.8K | |
| Feb 3, 2026 | Sheena Jonathan | Executive | Sale | 435 | $230.77 | $100.4K | |
| Jan 28, 2026 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sale | 928 | $237.66 | $220.6K | |
| Jan 28, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sale | 1,200 | $237.66 | $285.2K | |
| Jan 28, 2026 | Rabinowitz Daniel | SEC. AND CHIEF LEGAL OFFICER | Sale | 1,000 | $237.66 | $237.7K | |
| Jan 28, 2026 | Sheena Jonathan | Executive | Sale | 191 | $237.66 | $45.4K | |
| Jan 28, 2026 | Leonard Chapman Steven | Executive | Sale | 3,648 | $237.66 | $867.0K | Large |
| Jan 27, 2026 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sale | 784 | $240.53 | $188.6K | |
| Jan 27, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sale | 1,013 | $240.53 | $243.7K | |
| Jan 27, 2026 | Rabinowitz Daniel | SEC. AND CHIEF LEGAL OFFICER | Sale | 886 | $240.53 | $213.1K | |
| Jan 27, 2026 | Sheena Jonathan | Executive | Sale | 291 | $240.53 | $70.0K | |
| Jan 27, 2026 | Leonard Chapman Steven | Executive | Sale | 2,322 | $240.53 | $558.5K | Large |
| Jan 21, 2026 | Fesko John | PRESIDENT, CHIEF BUS. OFFICER | Sale | 339 | $235.00 | $79.7K | |
| Jan 21, 2026 | Moshkevich Solomon | PRESIDENT, CLINICALDIAGNOSTICS | Sale | 293 | $235.00 | $68.9K | |
| Jan 21, 2026 | Rabinowitz Daniel | SEC. AND CHIEF LEGAL OFFICER | Sale | 438 | $235.00 | $102.9K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 741 | $364.9M | 88.8% |
Exercise(M) | 407 | $33.6M | 8.2% |
Purchase(P) | 7 | $11.6M | 2.8% |
Payment(F) | 3 | $378.8K | 0.1% |
Award(A) | 117 | $347.3K | 0.1% |
Gift(G) | 18 | $0 | 0.0% |
Insider selling pressure at Natera, Inc. has increased, with 17 insiders executing 1293 transactions across all time. Total sales of $364.9M significantly outpace purchases of $11.6M, resulting in a net outflow of $353.4M. This selling activity appears largely discretionary, which may warrant closer attention from investors.